Reuben Laboratory
Alexandre Reuben, Ph.D.
Principal Investigator
- Departments, Labs and Institutes
- Labs
- Reuben Laboratory
Areas of Research
- Immunotherapy
- Adoptive Cell Therapy
- Lung Cancer
- Immunology
Our lab uses a combination of human samples and murine models to develop novel cell therapies for the treatment of lung cancer and other solid tumors. We are also invested in the development of innovative methodologies and technologies to overcome some of the most prominent hurdles facing immunotherapy of solid tumors.
Funding
American Association for Cancer Research
CPRIT High Impact High Reward
EGFR Resisters/LUNGevity
Exon20 Group
Happy Lungs Project
Lung Cancer Moon Shot®
Lung Cancer SPORE Developmental Research Project
National Institutes of Health/National Cancer Institute
Petrin Fund
RETpositive/LUNGevity Foundation
Rexanna’s Foundation for Fighting Lung Cancer
Salgado Family Research Fund
United States Department of Defense
Waun Ki Hong Lung Cancer Research Fund
News
Cancer immunologist: Research at MD Anderson is my calling - MD Anderson Cancerwise
RETpositive and LUNGevity Foundation Partner on Innovative Lung Cancer Research Award - LUNGevity Foundation
MD Anderson receives nearly $13 million from CPRIT to support research efforts - MD Anderson Newsroom
Two UW–Madison seniors were finalists this year for the Rhodes Scholarship - University of Wisconsin-Madison News
Three UW–Madison students named 2021 Goldwater Scholars - University of Wisconsin-Madison News
Scientists develop artificial intelligence method to predict anti-cancer immunity - ScienceDaily
For non-small cell lung cancer, T cell repertoire in lungs affects survival - MD Anderson Cancer Frontline